Shopping Cart

Subtotal $360.00
ANAVAR 50

ANAVAR 50 is an oral steroid which contains 50 mg of the hormone Oxandrolone.

ANAVAR 50 is considered one of the mildest steroids that there is. It is mildly anabolic and mildly androgenic. Even though it is a C-17 oral, it still has minimal effect on liver values even at higher doses. ANAVAR 50 also isn’t known by bodybuilders as the steroid for big mass gains. Rather, the mass that is gained by Oxandrolone will be quality gains and gains that likely to be kept after the steroid is no longer being used. Users of Oxandrolone often note a very good increase in strength.

Due to its extremely mild nature, Oxandrolone is also one of the most popular steroids amongst women bodybuilders. Oxandrolone has also been shown in studies to actually decrease bodyfat during use, making it a great choice for bodybuilders who are in the cutting phase of their training.

ANAVAR 50 is also very mild when it comes to shutting down the body’s ability to produce testosterone, making it a great choice for those looking to bridge between cycles while allowing the body to recover. Those looking to stack Oxandrolone with something may chose a low dose of a testosterone to do with it.

Clearly, ANAVAR 50 is a great all around steroid. Male bodybuilders will typically use ANAVAR 50 in doses of 50-100 mg a day for 6-12wks. ANAVAR 50 has a relatively short half life of about 8 hours. So one may chose to split dosages throughout the day in order to keep blood levels as stable as possible. Women bodybuilders typically find a dosage of 2.5-10mg to be effective for promoting muscle gains and strength without the great risk of side effects.

Substance Oxandrolone
Manufacturer Para Pharma, Europe
Packing
Hiraola's Shipping Icon
Free USA Standard Delivery

Designated day delivery

Hiraola's Shipping Icon
Freshyly Prepared Ingredients

Made for your delivery date

Hiraola's Shipping Icon
98% Of Anta Clients

Reach their personal goals set

Hiraola's Shipping Icon
Winner Of 15 Awards

Healthy food and drink 2019